Form 4: Core Scientific Director Booth Receives Stock Grants

Director Jeffrey David Booth receives restricted stock units from Core Scientific, Inc.

Summary

• Jeffrey David Booth, a director of Core Scientific, Inc., received two grants of restricted stock units (RSUs) on May 27, 2024.
• The first grant consists of 127,446 shares of common stock, vesting on January 23, 2027, contingent upon continued service as a non-employee director.
• The second grant consists of 47,793 shares of common stock, vesting on January 23, 2025, also contingent upon continued service as a non-employee director.
• Following these transactions, Booth directly owns 175,239 shares of Core Scientific common stock.

Sentiment

Score: 6

Explanation: The document is a standard SEC filing regarding stock grants, which is neutral in sentiment. It reflects standard compensation practices.

Positives

• The RSU grants to a director may align his interests with those of the shareholders, incentivizing him to work towards the company's long-term success.

Risks

• The vesting of the RSUs is contingent upon Booth's continued service as a non-employee director, creating a potential risk if he were to leave the company before the vesting dates.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedules of the RSUs.

Industry Context

This filing is a routine disclosure of stock-based compensation for a company director, which is a common practice in publicly traded companies to align management's interests with shareholders'.

Stakeholder Impact

• The RSU grants may have a slightly positive impact on shareholder sentiment as it aligns the director's interests with those of the shareholders.

Key Dates